Complete response · people with mycosis fungoides
IFN‐α + PUVA showed no clear difference in complete response (CR) compared with PUVA alone (low certainty).
1 finding from 1 review
Objective response rate · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Improvement of quality of life · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Common adverse effects · people with mycosis fungoides
1 finding from 1 review
Complete response · people with mycosis fungoides
It is very uncertain whether extracorporeal photopheresis changes complete response (Time point of measurement: three months of PUVA… compared with PUVA (very low certainty).
1 finding from 1 review
Objective response rate · people with mycosis fungoides
It is very uncertain whether extracorporeal photopheresis changes objective response rate (Time point of measurement: three months of… compared with PUVA (very low certainty).
1 finding from 1 review
Improvement of quality of life · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Frequency of skin damage (as recorded by clinicians according to STAR Skin Tear Classification) Outcome measured during 6 months · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Transepidermal water loss (TEWL) Measured using temperature‐adjusted g/m²/h with the Tewameter TM 300 (Courage + Khazaka, Cologne, Germany) Hahnel 2017: measured at 56 ± 4 days Shishido 2017: measured 15 minutes after wiping the skin with a dry to... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Stratum corneum hydration (SCH) (at baseline and day 56 ± 4) Hahnel 2017: measured at 56 ± 4 days in mid‐volar arm and lower leg in arbitrary units from 0 (no water) to 120 (on water) using the Corneometer CM 825 Gillis 2016: measured at 12 weeks ... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Erythema · people 60 years of age and older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinical score of dryness Hahnel 2017: measured at day 56 ± 4 using the Overall Dry Skin Score Boccanfuso 1978: measured after 10 applications using a non‐validated General Foot Condition Questionnaire including a Dryness Scale (1 = oily; 2 = norm... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Clinical score of itch · people 60 years of age and older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants cleared or almost cleared ‐ · chronic palmoplantar pustulosis
It is very uncertain whether triamcinolone acetonide 0.1% cream with occlusive dressing changes proportion of participants cleared or almost cleared ‐ compared with clobetasol cream 0.05% cream (very low certainty).
1 finding from 1 review
Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants achieving a 50% reduction in disease severity ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants without relapse in the long term ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with adverse effects ‐ measured over 8 weeks · chronic palmoplantar pustulosis
Topical vitamin D derivative showed no clear difference in proportion of participants with adverse effects ‐ measured over 8… compared with placebo (moderate certainty).
1 finding from 1 review
Proportion of participants cleared or almost cleared ‐ · chronic palmoplantar pustulosis
1 finding from 1 review
Proportion of participants with adverse effects serious or severe enough to have caused withdrawal ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found